@phdthesis{Riedel2007, author = {Riedel, Alexander}, title = {Untersuchungen zur endogenen MHC-Klasse-II-restringierten Pr{\"a}sentation nukle{\"a}rer Antigene}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-25183}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2007}, abstract = {Die endogene Pr{\"a}sentation von intrazellul{\"a}ren Antigenen auf Major-Histokompatibilit{\"a}tskomplex Klasse-II (MHC-II) -Molek{\"u}len ist von entscheidender Bedeutung f{\"u}r eine Reihe von immunologischen Prozessen. Die mechanistischen Grundlagen dieses Pr{\"a}sentationsweges sind aber noch weitgehend unverstanden. Ziel dieser Arbeit war es, einen Beitrag zum molekularen Verst{\"a}ndnis der Abl{\"a}ufe zu leisten, die an der endogenen Pr{\"a}sentation nukle{\"a}rer Antigene auf MHC-II-Molek{\"u}len beteiligt sind. Dazu sollte am Beispiel des nukle{\"a}r lokalisierten Modellantigens Neomycin-Phosphotransferase II (NucNeoR) sowie des viralen Kernantigens Epstein-Barr-virus nuclear antigen 3C (EBNA3C) und entsprechender antigenspezifischer MHC-II-restringierter CD4+ T-Zellen die verantwortlichen Pr{\"a}sentationswege in professionell und nicht-professionell antigenpr{\"a}sentierenden Zellen untersucht werden. In beiden Zellsystemen wurde NucNeoR {\"u}ber einen endogenen Pr{\"a}sentationsweg und nicht {\"u}ber die Freisetzung und Wiederaufnahme als exogenes Protein auf MHC-II-Molek{\"u}len pr{\"a}sentiert. Durch die Verwendung chemischer Inhibitoren konnte eine Beteiligung der Autophagie an der endogenen Antigenpr{\"a}sentation nachgewiesen werden. Da Autophagie ausschließlich im Zytoplasma stattfindet, wurde nach m{\"o}glichen Eintrittspforten f{\"u}r nukle{\"a}re Proteine in diesen Abbauweg gesucht. F{\"u}r die Autophagie-abh{\"a}ngige Pr{\"a}sentation von NucNeoR war weder ein CRM1-vermittelter aktiver Export des Antigens aus dem Kern ins Zytoplasma, noch eine Aufl{\"o}sung der Kernmembran im Rahmen der Zellteilung und der dadurch bedingten Durchmischung nukle{\"a}rer und zytoplasmatischer Bestandteile notwendig. Mit Hilfe eines konditionalen Antigenexpressionsystems und der Auftrennung antigenexprimierender Zellen nach Zellzyklusphasen konnte eine verst{\"a}rkte Antigenpr{\"a}sentation in der G1/0-Phase nachgewiesen werden, die mit fortschreitendem Zellzyklus immer mehr abnahm. Die Antigenpr{\"a}sentation korrelierte dabei mit der ebenfalls im Laufe des Zellzyklus abnehmenden Transkriptions- bzw. Translationsrate des Antigens, aber nicht mit der absoluten Menge an Antigen in den Zellen. Bei abgeschalteter Antigentranskription dagegen korrelierte die Antigenpr{\"a}sentation mit der MHC-II-Oberfl{\"a}chenexpression, die von der G1/0- bis hin zur G2/M-Phase kontinuierlich zunahm. Eine {\"a}hnliche Korrelation von Antigentranskription/ Antigentranslation und Autophagie-abh{\"a}ngiger Antigenpr{\"a}sentation wurde auch f{\"u}r EBNA3C und die zytoplasmatisch lokalisierte NeoR-Variante beobachtet. Diese Ergebnisse identifizieren die Autophagie-abh{\"a}ngige Pr{\"a}sentation neusynthetisierter Proteine als den verantwortlichen molekularen Mechanismus f{\"u}r die endogene Pr{\"a}sentation der untersuchten nukle{\"a}ren Antigene auf MHC-II-Molek{\"u}len. Durch die Kopplung von Translation und autophagischem Abbau erlangen Proteine unabh{\"a}ngig von ihrer subzellul{\"a}ren Lokalisation Zugang zu diesem Pr{\"a}sentationsweg und erweitern so das Spektrum der intrazellul{\"a}ren Antigene, die einer CD4+ T-Zell{\"u}berwachung unterliegen.}, subject = {Autophagie}, language = {de} } @article{SiegmundWagnerWajant2022, author = {Siegmund, Daniela and Wagner, Jennifer and Wajant, Harald}, title = {TNF receptor associated factor 2 (TRAF2) signaling in cancer}, series = {Cancers}, volume = {14}, journal = {Cancers}, number = {16}, issn = {2072-6694}, doi = {10.3390/cancers14164055}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-286073}, year = {2022}, abstract = {Tumor necrosis factor (TNF) receptor associated factor-2 (TRAF2) has been originally identified as a protein interacting with TNF receptor 2 (TNFR2) but also binds to several other receptors of the TNF receptor superfamily (TNFRSF). TRAF2, often in concert with other members of the TRAF protein family, is involved in the activation of the classical NFκB pathway and the stimulation of various mitogen-activated protein (MAP) kinase cascades by TNFRSF receptors (TNFRs), but is also required to inhibit the alternative NFκB pathway. TRAF2 has also been implicated in endoplasmic reticulum (ER) stress signaling, the regulation of autophagy, and the control of cell death programs. TRAF2 fulfills its functions by acting as a scaffold, bringing together the E3 ligase cellular inhibitor of apoptosis-1 (cIAP1) and cIAP2 with their substrates and various regulatory proteins, e.g., deubiquitinases. Furthermore, TRAF2 can act as an E3 ligase by help of its N-terminal really interesting new gene (RING) domain. The finding that TRAF2 (but also several other members of the TRAF family) interacts with the latent membrane protein 1 (LMP1) oncogene of the Epstein-Barr virus (EBV) indicated early on that TRAF2 could play a role in the oncogenesis of B-cell malignancies and EBV-associated non-keratinizing nasopharyngeal carcinoma (NPC). TRAF2 can also act as an oncogene in solid tumors, e.g., in colon cancer by promoting Wnt/β-catenin signaling. Moreover, tumor cell-expressed TRAF2 has been identified as a major factor-limiting cancer cell killing by cytotoxic T-cells after immune checkpoint blockade. However, TRAF2 can also be context-dependent as a tumor suppressor, presumably by virtue of its inhibitory effect on the alternative NFκB pathway. For example, inactivating mutations of TRAF2 have been associated with tumor development, e.g., in multiple myeloma and mantle cell lymphoma. In this review, we summarize the various TRAF2-related signaling pathways and their relevance for the oncogenic and tumor suppressive activities of TRAF2. Particularly, we discuss currently emerging concepts to target TRAF2 for therapeutic purposes.}, language = {en} } @article{AuerHuegelschaefferFischeretal.2020, author = {Auer, Daniela and H{\"u}gelsch{\"a}ffer, Sophie D. and Fischer, Annette B. and Rudel, Thomas}, title = {The chlamydial deubiquitinase Cdu1 supports recruitment of Golgi vesicles to the inclusion}, series = {Cellular Microbiology}, volume = {22}, journal = {Cellular Microbiology}, number = {5}, doi = {10.1111/cmi.13136}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-208675}, pages = {e13136}, year = {2020}, abstract = {Chlamydia trachomatis is the main cause of sexually transmitted diseases worldwide. As obligate intracellular bacteria Chlamydia replicate in a membrane bound vacuole called inclusion and acquire nutrients for growth and replication from their host cells. However, like all intracellular bacteria, Chlamydia have to prevent eradication by the host's cell autonomous system. The chlamydial deubiquitinase Cdu1 is secreted into the inclusion membrane, facing the host cell cytosol where it deubiquitinates cellular proteins. Here we show that inactivation of Cdu1 causes a growth defect of C. trachomatis in primary cells. Moreover, ubiquitin and several autophagy receptors are recruited to the inclusion membrane of Cdu1-deficient Chlamydia . Interestingly, the growth defect of cdu1 mutants is not rescued when autophagy is prevented. We find reduced recruitment of Golgi vesicles to the inclusion of Cdu1 mutants indicating that vesicular trafficking is altered in bacteria without active deubiquitinase (DUB). Our work elucidates an important role of Cdu1 in the functional preservation of the chlamydial inclusion surface.}, language = {en} } @article{KugerFlentjeDjuzenova2015, author = {Kuger, Sebastian and Flentje, Michael and Djuzenova, Cholpon S.}, title = {Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization}, series = {Radiation Oncology}, volume = {10}, journal = {Radiation Oncology}, number = {214}, doi = {10.1186/s13014-015-0514-5}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-126104}, year = {2015}, abstract = {Background The mitogen-activated protein kinases (MAPK) and the phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) pathways are intertwined on various levels and simultaneous inhibition reduces tumorsize and prolonges survival synergistically. Furthermore, inhibiting these pathways radiosensitized cancer cells in various studies. To assess, if phenotypic changes after perturbations of this signaling network depend on the genetic background, we integrated a time series of the signaling data with phenotypic data after simultaneous MAPK/ERK kinase (MEK) and PI3K/mTOR inhibition and ionizing radiation (IR). Methods The MEK inhibitor AZD6244 and the dual PI3K/mTOR inhibitor NVP-BEZ235 were tested in glioblastoma and lung carcinoma cells, which differ in their mutational status in the MAPK and the PI3K/mTOR pathways. Effects of AZD6244 and NVP-BEZ235 on the proliferation were assessed using an ATP assay. Drug treatment and IR effects on the signaling network were analyzed in a time-dependent manner along with measurements of phenotypic changes in the colony forming ability, apoptosis, autophagy or cell cycle. Results Both inhibitors reduced the tumor cell proliferation in a dose-dependent manner, with NVP-BEZ235 revealing the higher anti-proliferative potential. Our Western blot data indicated that AZD6244 and NVP-BEZ235 perturbed the MAPK and PI3K/mTOR signaling cascades, respectively. Additionally, we confirmed crosstalks and feedback loops in the pathways. As shown by colony forming assay, the AZD6244 moderately radiosensitized cancer cells, whereas NVP-BEZ235 caused a stronger radiosensitization. Combining both drugs did not enhance the NVP-BEZ235-mediated radiosensitization. Both inhibitors caused a cell cycle arrest in the G1-phase, whereas concomitant IR and treatment with the inhibitors resulted in cell line- and drug-specific cell cycle alterations. Furthermore, combining both inhibitors synergistically enhanced a G1-phase arrest in sham-irradiated glioblastoma cells and induced apoptosis and autophagy in both cell lines. Conclusion Perturbations of the MEK and the PI3K pathway radiosensitized tumor cells of different origins and the combination of AZD6244 and NVP-BEZ235 yielded cytostatic effects in several tumor entities. However, this is the first study assessing, if the combination of both drugs also results in synergistic effects in terms of radiosensitivity. Our study demonstrates that simultaneous treatment with both pathway inhibitors does not lead to synergistic radiosensitization but causes cell line-specific effects.}, language = {en} } @phdthesis{Ehebauer2020, author = {Ehebauer, Franziska}, title = {Regulation of Nicotinamide N-methyltransferase Expression in Adipocytes}, doi = {10.25972/OPUS-21764}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-217645}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2020}, abstract = {Nicotinamide N-methyltransferase (NNMT) is a new regulator of energy homeostasis. Its expression is increased in models of obesity and diabetes. An enhanced NNMT level is also caused by an adipose tissue-specific knockout of glucose transporter type 4 (GLUT4) in mice, whereas the overexpression of this glucose transporter reduced the NNMT expression. Furthermore, the knockdown of the enzyme prevents mice from diet-induced obesity (DIO) and the recently developed small molecule inhibitors for NNMT reverses the DIO. These previous findings demonstrated the exclusive role of NNMT in adipose tissue and further make it to a promising target in obesity treatment. However, the regulation mechanism of this methyltransferase is not yet clarified. The first part of the thesis focus on the investigation whether pro-inflammatory signals are responsible for the enhanced NNMT expression in obese adipose tissue because a hallmark of this tissue is a low-level chronic inflammation. Indeed, the NNMT mRNA in our study was elevated in obese patients compared with the control group, whereas the GLUT4 mRNA expression does not differ between lean and obese humans. To analyze whether pro inflammatory signals, like interleukin (IL 6) and tumor necrosis factor α (TNF-α), regulate NNMT expression 3T3-L1 adipocytes were treated with these cytokines. However, IL 6, TNF α, and leptin, which is an alternative activator of the JAK/STAT pathway, did not affect the NNMT protein or mRNA level in differentiated 3T3-L1 adipocytes. The mRNA and protein levels were measured by quantitative polymerase chain reaction (qPCR) and western blotting. In the second part of this study, 3T3-L1 adipocytes were cultivated with varying glucose concentrations to show whether NNMT expression depends on glucose availability. Further studies with activators and inhibitors of AMP-activated protein kinase (AMPK) and mechanistic target of rapamycin (mTOR) signaling pathways were used to elucidate the regulation mechanism of the enzyme. The glucose deprivation of differentiated 3T3-L1 adipocytes led to a 2-fold increase in NNMT expression. This effect was confirmed by the inhibition of the glucose transports with phloretin as well as the inhibition of glycolysis with 2-deoxyglucose (2-DG). AMPK serves as an intracellular energy sensor and the pharmacological activation of it enhanced the NNMT expression. This increase was also caused by the inhibition of mTOR. Conversely, the activation of mTOR using MHY1485 prevented the effect of glucose deprivation on NNMT. Furthermore, the NNMT up-regulation was also blocked by the different autophagy inhibitors. Taken together, NNMT plays a critical role in autophagy in adipocytes, because an inhibition of this process prevented the augmented NNMT expression during glucose starvation. Moreover, the effect on NNMT protein and mRNA level depends on AMPK and mTOR. However, pro-inflammatory signals did not affect the expression. Further in vivo studies have to clarify whether AMPK activation and mTOR inhibition as well as autophagy are responsible for the increased NNMT levels in obese adipose tissue. In future this methyltransferase emerges as an awesome therapeutic target for obesity.}, subject = {Fettzelle}, language = {en} } @article{LueningschroerBinottiDombertetal.2017, author = {L{\"u}ningschr{\"o}r, Patrick and Binotti, Beyenech and Dombert, Benjamin and Heimann, Peter and Perez-Lara, Angel and Slotta, Carsten and Thau-Habermann, Nadine and von Collenberg, Cora R. and Karl, Franziska and Damme, Markus and Horowitz, Arie and Maystadt, Isabelle and F{\"u}chtbauer, Annette and F{\"u}chtbauer, Ernst-Martin and Jablonka, Sibylle and Blum, Robert and {\"U}{\c{c}}eyler, Nurcan and Petri, Susanne and Kaltschmidt, Barbara and Jahn, Reinhard and Kaltschmidt, Christian and Sendtner, Michael}, title = {Plekhg5-regulated autophagy of synaptic vesicles reveals a pathogenic mechanism in motoneuron disease}, series = {Nature Communications}, volume = {8}, journal = {Nature Communications}, number = {678}, doi = {10.1038/s41467-017-00689-z}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-170048}, year = {2017}, abstract = {Autophagy-mediated degradation of synaptic components maintains synaptic homeostasis but also constitutes a mechanism of neurodegeneration. It is unclear how autophagy of synaptic vesicles and components of presynaptic active zones is regulated. Here, we show that Pleckstrin homology containing family member 5 (Plekhg5) modulates autophagy of synaptic vesicles in axon terminals of motoneurons via its function as a guanine exchange factor for Rab26, a small GTPase that specifically directs synaptic vesicles to preautophagosomal structures. Plekhg5 gene inactivation in mice results in a late-onset motoneuron disease, characterized by degeneration of axon terminals. Plekhg5-depleted cultured motoneurons show defective axon growth and impaired autophagy of synaptic vesicles, which can be rescued by constitutively active Rab26. These findings define a mechanism for regulating autophagy in neurons that specifically targets synaptic vesicles. Disruption of this mechanism may contribute to the pathophysiology of several forms of motoneuron disease.}, language = {en} } @article{KugerCoerekPolatetal.2014, author = {Kuger, Sebastian and C{\"o}rek, Emre and Polat, B{\"u}lent and K{\"a}mmerer, Ulrike and Flentje, Michael and Djuzenova, Cholpon S.}, title = {Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines under Normoxic and Hypoxic Conditions}, doi = {10.4137/BCBCR.S13693}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-112708}, year = {2014}, abstract = {In the present study, we assessed, if the novel dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor NVP-BEZ235 radiosensitizes triple negative (TN) MDA-MB-231 and estrogen receptor (ER) positive MCF-7 cells to ionizing radiation under various oxygen conditions, simulating different microenvironments as occurring in the majority of breast cancers (BCs). Irradiation (IR) of BC cells cultivated in hypoxic conditions revealed increased radioresistance compared to normoxic controls. Treatment with NVP-BEZ235 completely circumvented this hypoxia-induced effects and radiosensitized normoxic, reoxygenated, and hypoxic cells to similar extents. Furthermore, NVP-BEZ235 treatment suppressed HIF-1α expression and PI3K/mTOR signaling, induced autophagy, and caused protracted DNA damage repair in both cell lines in all tested oxygen conditions. Moreover, after incubation with NVP-BEZ235, MCF-7 cells revealed depletion of phospho-AKT and considerable signs of apoptosis, which were signifi-cantly enhanced by radiation. Our findings clearly demonstrate that NVP-BEZ235 has a clinical relevant potential as a radiosensitizer in BC treatment.}, language = {en} } @article{AnnunziatavandeVlekkertWolfetal.2019, author = {Annunziata, Ida and van de Vlekkert, Diantha and Wolf, Elmar and Finkelstein, David and Neale, Geoffrey and Machado, Eda and Mosca, Rosario and Campos, Yvan and Tillman, Heather and Roussel, Martine F. and Weesner, Jason Andrew and Fremuth, Leigh Ellen and Qiu, Xiaohui and Han, Min-Joon and Grosveld, Gerard C. and d'Azzo, Alessandra}, title = {MYC competes with MiT/TFE in regulating lysosomal biogenesis and autophagy through an epigenetic rheostat}, series = {Nature Communications}, volume = {10}, journal = {Nature Communications}, doi = {10.1038/s41467-019-11568-0}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-221189}, year = {2019}, abstract = {Coordinated regulation of the lysosomal and autophagic systems ensures basal catabolism and normal cell physiology, and failure of either system causes disease. Here we describe an epigenetic rheostat orchestrated by c-MYC and histone deacetylases that inhibits lysosomal and autophagic biogenesis by concomitantly repressing the expression of the transcription factors MiT/TFE and FOXH1, and that of lysosomal and autophagy genes. Inhibition of histone deacetylases abates c-MYC binding to the promoters of lysosomal and autophagy genes, granting promoter occupancy to the MiT/TFE members, TFEB and TFE3, and/or the autophagy regulator FOXH1. In pluripotent stem cells and cancer, suppression of lysosomal and autophagic function is directly downstream of c-MYC overexpression and may represent a hallmark of malignant transformation. We propose that, by determining the fate of these catabolic systems, this hierarchical switch regulates the adaptive response of cells to pathological and physiological cues that could be exploited therapeutically.}, language = {en} } @article{ScherzadMeyerKleinsasseretal.2017, author = {Scherzad, Agmal and Meyer, Till and Kleinsasser, Norbert and Hackenberg, Stephan}, title = {Molecular Mechanisms of Zinc Oxide Nanoparticle-Induced Genotoxicity Short Running Title: Genotoxicity of ZnO NPs}, series = {Materials}, volume = {10}, journal = {Materials}, number = {12}, doi = {10.3390/ma10121427}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-169948}, pages = {1427}, year = {2017}, abstract = {Background: Zinc oxide nanoparticles (ZnO NPs) are among the most frequently applied nanomaterials in consumer products. Evidence exists regarding the cytotoxic effects of ZnO NPs in mammalian cells; however, knowledge about the potential genotoxicity of ZnO NPs is rare, and results presented in the current literature are inconsistent. Objectives: The aim of this review is to summarize the existing data regarding the DNA damage that ZnO NPs induce, and focus on the possible molecular mechanisms underlying genotoxic events. Methods: Electronic literature databases were systematically searched for studies that report on the genotoxicity of ZnO NPs. Results: Several methods and different endpoints demonstrate the genotoxic potential of ZnO NPs. Most publications describe in vitro assessments of the oxidative DNA damage triggered by dissoluted Zn2+ ions. Most genotoxicological investigations of ZnO NPs address acute exposure situations. Conclusion: Existing evidence indicates that ZnO NPs possibly have the potential to damage DNA. However, there is a lack of long-term exposure experiments that clarify the intracellular bioaccumulation of ZnO NPs and the possible mechanisms of DNA repair and cell survival.}, language = {en} } @article{FraunholzSinha2012, author = {Fraunholz, Martin and Sinha, Bhanu}, title = {Intracellular staphylococcus aureus: Live-in and let die}, series = {Frontiers in Cellular and Infection Microbiology}, volume = {2}, journal = {Frontiers in Cellular and Infection Microbiology}, number = {43}, doi = {10.3389/fcimb.2012.00043}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-123374}, year = {2012}, abstract = {Staphylococcus aureus uses a plethora of virulence factors to accommodate a diversity of niches in its human host. Aside from the classical manifestations of S. aureus-induced diseases, the pathogen also invades and survives within mammalian host cells. The survival strategies of the pathogen are as diverse as strains or host cell types used. S. aureus is able to replicate in the phagosome or freely in the cytoplasm of its host cells. It escapes the phagosome of professional and non-professional phagocytes, subverts autophagy, induces cell death mechanisms such as apoptosis and pyronecrosis, and even can induce anti-apoptotic programs in phagocytes. The focus of this review is to present a guide to recent research outlining the variety of intracellular fates of S. aureus.}, language = {en} }